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Abstract
Technology is changing at a rapid rate, opening up new possibilities within the health care domain. Advances such as open source
hardware, personal medical devices, and mobile phone apps are creating opportunities for custom-made medical devices and
personalized care. However, they also introduce new challenges in balancing the need for regulation (ensuring safety and
performance) with the need to innovate flexibly and efficiently. Compared with the emergence of new technologies, health
technology design standards and regulations evolve slowly, and therefore, it can be difficult to apply these standards to the latest
developments. For example, current regulations may not be suitable for approaches involving open source hardware, an increasingly
popular way to create medical devices in the maker community. Medical device standards may not be flexible enough when
evaluating the usability of mobile medical devices that can be used in a multitude of different ways, outside of clinical settings.
Similarly, while regulatory guidance has been updated to address the proliferation of health-related mobile phone apps, it can be
hard to know if and when these regulations apply. In this viewpoint, we present three examples of novel medical technologies to
illustrate the types of regulatory issues that arise in the current environment. We also suggest opportunities for support, such as
advances in the way we review and monitor medical technologies.
(JMIR mHealth uHealth 2015;3(2):e64)  doi: 10.2196/mhealth.3918
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Introduction
In recent years, there has been a rapid, major, and continued
advance in scientific discovery and technology proliferation
that provides the means to support health care in new ways. For
example, the percentage of UK adults who own a mobile phone
has risen from 39% to 51% in just 1 year [1]. The proliferation
of mobile phones and pervasiveness of health apps [2] allow
patients to manage and track their health conditions on the go,
which turns mobile phones into a tool for health-related behavior
change [3]. This means that care can be provided outside of
clinical settings [4,5] and technology can be used to address
growing health care demands, such as an increasing prevalence
of chronic conditions and aging populations [6].
A growing number of medical and health-related technologies
becoming available can be adapted to support personal care,
both in terms of customized hardware and software. For
example, electronic devices are not only becoming ubiquitous,
but are also easier to make; three-dimensional printers are
becoming significantly cheaper (the market is predicted to grow
by 500% in 5 years [7]). Three-dimensional printers are devices
that create three-dimensional objects based on an electronic
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data source containing a three-dimensional model. As a result,
these printers have opened up the possibility to produce
custom-made medical devices as needed, where needed [8],
which is sometimes referred to as “hyperlocal micro
manufacturing” [9]. These types of advances will continue to
provide solutions to health care problems that seemed near
impossible to solve a decade ago, and they generate their own
unique considerations about how these technologies fit into
existing regulatory frameworks.
The need for regulation has long been established in the health
care domain and has led to manufacturers considering safety
during the design and evaluation of medical devices [10] (for
a US perspective on ethical standards, see [11]). Medical device
manufacturers often use medical device standards (eg, [12]) to
guide their design and production processes and to comply with
regulatory requirements. For example, the IEC 60601 [13] series
puts in place requirements relating to safety and effectiveness,
focusing on various aspects of the product (eg, electrical
integrity, alarms). The IEC 62366 [14] standard describes a
usability engineering process, to satisfy similar requirements,
which is linked to a risk analysis standard (ISO 14971 [15]).
Unfortunately, novel and personal medical technologies do not
always fit into the process specified in standards because they
move away from what is currently and generally accepted as
good practice to a situation in which there may be little or no
precedent for comparison. Health care technology innovation
may be hurt by the current regulatory system [16]. Sometimes
standards do not provide sufficient design and evaluation criteria
for novel technologies that differ significantly from equivalent
predecessors; sometimes regulation may stifle innovation to the
point where new technology cannot benefit the health care
system (eg, through the time or cost constraints); however,
sometimes existing systems may not be applied at all, or they
are not applicable when it comes to modern technology.
In this paper, we open a discussion about the challenges to
existing regulatory systems posed by novel and personal health
care technologies. By presenting three examples that we have
encountered as part of our research, we highlight some of the
issues. First, we describe an open source infusion pump that
raises questions about how to control the quality of custom-made
medical devices. Next, we present our research on mobile
medical devices that challenges the methods of evaluation set
out in current medical usability standards. Finally, we discuss
the design of a mobile phone app for medication adherence that
may or may not be governed by the existing regulations.
Although papers focusing on regulatory challenges have already
been published (eg, [17]), we contribute to the discussion by
introducing three case studies, outlining the issues with standards
and regulations, and proposing ways to address these issues.
Novel Health Care Technologies
Overview
The following examples describe the tension between health
care innovation and regulation. They come from research
conducted as a part of the Computer-Human Interaction for
Medical Devices (CHI + MED) project, focusing on developing
tools to support safe and usable health technology (medical
devices). The following section presents three technologies:
open source hardware, mobile health care technologies, and
health-related mobile phone apps. It describes the regulatory
challenges that may be encountered in the development of these
kinds of devices, and identifies opportunities for addressing
these issues.
Example 1: Open Source Medical Devices
Background
Open source hardware is an emerging business model where
the design files of a product, including the circuit schematics,
source code, and physical design, are made publicly available
under a license so that anyone can study, modify, distribute,
make, and sell the design or hardware based on that design. In
recent years, three-dimensional printers have made possible a
rapid production of customized medical devices [8], from fitted
mechanical limbs [18] and mobile phone-connected microscopes
[19] to parts for syringe pumps (as shown in Figure 1). Coupled
with an open source approach, more can be achieved with less
cost, because production can occur in-house, based on a freely
available design.
Building on work of the Michigan Tech Open Sustainability
Technology (MOST) group [20], we are demonstrating the
process of building an open source syringe pump that
implements design principles and interface guidelines published
as part of the CHI + MED project. We are creating a complete
open platform for further research and development [21]. Design
files and software made public by MOST, under an open source
license, are at the core of the project. The approach not only
leads to economic savings through a reduction in the life-cycle
cost [22], but also it allows others to improve on the design,
share the improvements with others, and get rapid feedback
from the end user. This openness can benefit multiple
stakeholders and lead to effective technology and improved
patient outcomes (for equivalent arguments relating to open
source software, see [23]). It can also allow staff from hospital
departments such as medical physics and clinical engineering
to repair and customize their own devices, reducing a reliance
on external providers.
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Figure 1. Three-dimensional printing technology (image credit Gerrit Niezen; image license CC-BY).
Regulatory Challenges
The ability to modify someone else’s designs and the ease of
rapid and unique production could interfere with formal
quality-control processes, implicit in the existing medical device
regulation. Although three-dimensional printing is a tool for
prototyping and not for long-term use and reuse, it is possible
to see how this technology could be used for the latter purpose.
Existing standards may not be practical as the documentation
required for review and approval may be disproportionate when
the design is limited to a very small number of production units.
While the steps that are followed during the development and
testing of medical devices are specified and controlled by
standards (in the European Union, those listed in [12]), the
process followed during the aforementioned activities may be
ad hoc. For example, processes specified in medical device
standards were created with traditional manufacturing process
in mind. At a certain point, a design would be frozen and
considered complete. This is not the case when devices can be
continuously improved upon by the creator and others. The need
for documentation and testing that closely adheres to standards
may remove the flexibility that novel approaches bring.
Repeated design changes and the requirement for oversight from
a review body may be cumbersome on both sides. Although
there are many advantages to realizing the benefits of existing
process, systems need to be made agile and proportionate.
Opportunities
With an open source approach, there is an opportunity to share
the rationale behind the design, the process used to derive the
design, as well as the design itself. For example, online
documentation tools such as wikis and version control software
can be adapted to provide a better overview of the development
workflow and process that has been followed. It is also possible
to share evaluation results; if a component or design has evolved
over time, knowing how and why this has happened could help
those at distance understand the constraints of a solution.
Through sharing and periodically updating these documents,
duplication of effort can be avoided. For example, it does not
always make sense for the same component to undergo the same
testing by multiple parties. Moreover, documentation can be
scrutinized by multiple specialists, without being confounded
by the proprietary nature of “closed” solutions. Therefore, rather
than requiring the same documentation as that for traditionally
manufactured devices, regulation could involve transparent
records of all components and changes made to those
components, including the rationale and assumptions. This
would help to support the quality of such devices without stifling
innovation, with the onus being on those implementing a
solution to check and review these documents.
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Example 2: Mobile Health Care Technologies and
Home Use Devices
Background
Given the need to support care outside of clinical settings,
technologies are also being developed to provide increasing
autonomy and self-care. Our research on CHI + MED
investigates how people use technology to manage their health
care needs during their day-to-day lives. One such set of
technologies includes devices used in the self-management of
type 1 diabetes, a complex chronic condition that requires
significant personal responsibility over a lifetime [24]. A
common form of diabetes technology is the glucose meter that
is used to measure blood glucose levels for everyday medication
dose calculations, as well as for identifying high and low blood
sugar levels, which are dangerous in the long term and
potentially fatal in the short term, respectively [25]. Thanks to
advances in technology and human factors engineering, glucose
meters can be used by people with minimal or no training. They
are easier to carry, easier to use, and can store results. This
empowers people with diabetes and grants independence [26].
However, our work shows that complexities of everyday life
such as people’s work life, romantic life, friendships, hobbies,
travel, holidays [27], or whom they are with [28,29] impact on
the use of these devices (Figure 2). Understanding these factors
is incredibly complex [30], but necessary to ensure glucose
meters are reliable and meet users needs. The problem is that
the evaluation methods suggested by standards are not adequate
in addressing everyday use, as they have been developed with
a focus on technology used in clinical environments, where
there is more certainty about the characteristics of the work
place and levels of training.
Figure 2. Everyday life and a glucose meter (image credit Aisling Ann O'Kane; image license CC-BY).
Regulatory Challenges
Mobile health care technologies used for self-management, such
as glucose meters used by people with diabetes, are medical
devices and are regulated as such. Standard usability engineering
process applies, such as IEC 62366 [14], for these cases.
These personal health care devices are used in the context of
people’s everyday lives, yet the design and evaluation involves
the same usability standards as medical devices found in
hospitals. The definition of usability is the same (see [14]). The
focus is on the device’s effectiveness, efficiency, ease of
learning, and user satisfaction, in what is assumed to be a
controlled context. This standardized usability evaluation
practice makes it difficult to support the range of individual
needs of users outside clinical environments: in their homes,
on the go, as a part of their everyday life. This can be seen by
accounts of the application of standard usability engineering
process [31], such as IEC 62366 [14]. Although such standards
are voluntary, and the techniques are illustrative, many
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companies feel that they have little option but to adhere to their
content [32].
Although standards such as IEC 62366 [14] suggest taking
context into account using techniques such as task analysis,
contextual inquiry, functional analysis, testing in simulated
clinical environments, and field testing, how they might be
adapted or tailored to represent the unstable context of everyday
life is not elaborated on. These methods may not capture the
influences that a person’s life might have on the safe use and
adoption of these devices, outside the confines of a hospital.
Influences could include the emotional aspects of self-care or
the social impact of bystanders, when using a device in front
of others.
Likewise, it can be unmanageable to scope everyday health care
technologies, for the purposes of making assumptions about
their use. Pervasive technologies are used by all sorts of people,
in all sorts of situations, and in all sorts of contexts. Individual
differences are inevitable, and they have been shown to impact
users’ experience and challenge the design and development of
products [33]. This raises concerns for health care technologies
where differences might result in safety risks.
These concerns can be addressed by limiting the scope to a
certain user profile or context, but this may not be possible for
medical technologies designed for a particular condition, not
for a particular user group. Another approach is to configure
products based on user needs, for example, allowing
customization of the exterior shell [34] and/or allowing
configuration of the user interface. This poses a dilemma for
evaluation in that as the number of possible configurations
increases, the burden associated with management, evaluation,
and support also increases [35,36]. On the one hand, allowing
for flexibility reduces the chance of nonadoption or
noncompliance; on the other hand, complexity in the product
adds to the resource required to develop and maintain it.
Opportunities
One option would be to increase emphasis on postmarket
assessment, such as monitoring the use of equipment in context
(including self-report), alongside conducting research to
understand how users are really experiencing this type of
equipment. Exploratory qualitative methods have been applied
in other domains to focus on the situated use of interactive
devices and they are also relevant here.
For instance, diary studies [37] involve users taking note of
when, where, how, and why they use their device in their
everyday life. They avoid the invasiveness of observation.
Autoethnography, a form of self-study, is a quick and easy way
to probe the everyday use of mobile medical devices [30]. Even
though there has been progress toward using exploratory
methods to investigate the context of use [38], standards are
lacking in their treatment of situated user experience. Situated
user experience relates to the notion that the localized context
is an important factor in determining how people will experience
and interact with technology. As it has been shown that context
influences the use of pervasive health care technologies [30],
testing technology away from this context (e.g. in a laboratory)
does not anticipate how well the technology will meet the needs
of the user. There is therefore an opportunity for standards to
support consideration of a broader range of context, given the
mobile nature of devices, and use outside of clinical settings.
The inclusion of exploratory qualitative methods would allow
for this by probing context of use and revealing of individual
differences.
Example 3: Health-Related Mobile Phone Apps
Background
Whereas personal medical technologies can provide benefits to
those who require specific equipment, dedicated mobile phone
apps have potential to be advantageous to almost anyone. People
have access to thousands of free health-related mobile phone
apps [39,40]. They range from behavior change apps supporting
people who want to improve their health and well-being [3],
for example, apps supporting smoking cessation (eg,
SmokeFree28 [41]), or providing informed choice regarding
alcohol intake (eg, Drinks Meter [42]), to apps focusing on
specific conditions (eg, pain management [43]). They can be
used to prevent forgetfulness (eg, medication reminder apps
[44]) and general adherence support apps [45]. As people tend
to keep their mobile phones close and hardly ever switch them
off, health apps can provide useful functions at any time. They
are always at hand to help track the on-going behavior.
Another (currently unreleased) example would be a software
app to support oral contraception adherence. We are currently
researching how mobile phone apps could be used to reduce
unintentional nonadherence. This involves developing a
medication reminder app that supports the formation of
medication-taking habits and assists users as they search for the
best way to embed medication taking into their daily routine;
how this could be achieved is described in [44]. One of the
major challenges to understanding the approach required to
evaluate this type of software is the fact that it is not entirely
clear whether an app should be regulated as a medical device.
Regulatory Challenges
During our research we have identified many issues concerning
the certification of health-related apps. One example relates to
the wording that is used to describe them. Many apps make
medical claims and by doing so, could pose a serious public
health issue, especially they are if ineffective or inaccurate [40].
Regulation is required and although guidance on health-related
software and apps exists [46-49], it may not be clear whether
such apps should be covered by regulations. Moreover, when
considering the market as a whole, regulations may be bypassed
and in some cases, ignored. In the European Union, in some
cases, health-related apps fall under the control of the medical
devices directive. In this scheme, assuming the software is not
an accessory to a device, classification rules can treat medical
standalone software as a comparatively low risk [49]:
“The classification rules were not written with software in mind.
Due to the restrictive nature of Rules 9-11 of Annex IX to
Directive 93/42/EEC, a large number of software devices
therefore fall in Class I, where compliance is based on
self-declaration, ie, no third party assessment.”
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As a result, the product can be self-certified by the organization
producing it. This raises concerns about the level of peer review
and testing that this type of software receives.
In other cases, software can be used in a medical context, but
not for a medical purpose, and not considered to be a medical
device. For example, based on similar UK Medicines and Health
Care Products Regulatory Agency (MHRA) advice, an app
could use an accelerometer or gyroscope to detect falls in
epileptic patients and therefore be regulated as a medical device.
However, if the same technology is used to measure steps or
detect whether an elderly person has got up from a chair or a
bed in a social care context, the regulation would not apply [47].
This is important because it impacts on the type of testing that
would apply (both in terms of usability and general safety and
performance requirements), as well as the approach to
monitoring the device in situ.
To help determine whether an app should be treated as a medical
device, the MHRA has produced the following list of keywords
and phrases that if used in the app’s description indicate that it
should be regulated: amplify, analysis, interpret, alarms,
calculates, controls, converts, detects, diagnose, measures, and
monitors [47]. Take the example of an app that aims to send
alerts to users to check whether they have taken their medication
and records how many times they say they did not. Based on
this information, it can suggest changes to the routine. Therefore,
it could be said that the app monitors users and occasionally
alarms when their behavior needs to be modified. Does it mean
the app should be certified?
If the app is labeled as a tool for supporting medication-taking
habits, then the answer is likely to be yes. However, if the
wording changes to simply habits, then even though the
functionality stays the same, does the answer become no? Such
a small change in wording could be enough to avoid device
regulations, but it might not even be needed. Some developers
simply publish their health apps without worrying about
regulations at all, whereas others add liability disclaimers to
app descriptions [40]. Based on the US guidance relating to
mobile medical applications [46], “Mobile apps that keep track
of medications and provide user-configured reminders for
improved medication adherence” are an example of “...mobile
apps for which FDA intends to exercise enforcement discretion”
[46].
Based on both US and UK frameworks, this type of app may
or may not be regulated. This problem has been covered in
recent UK media reports [50], where there are several examples
of gray areas and products that sit on the boundary. In many
respects there is not anything new about technologies that sit
on the boundary between regulated and unregulated products.
The concern is that the assumptions used to determine whether
technology is regulated as a medical device may not reflect how
the technology is actually used (eg, unregulated apps being used
in a context when a regulated app is appropriate).
Of specific concern is the quality of the software code and
process used during programming, which may be invisible once
the software has been released. Even if there is intent to follow
medical device standards, they may be difficult to realize in
practice. For example, the medical device usability standard
IEC 62366 [14] combines evaluation of safety and usability,
which may be in opposition to each other [35]. Other standards
may be insufficient when it comes to the testing of software:
they may not require exhaustive testing, complete coverage, or
proof that a solution is correct by construction [51]. This is
evident in the number of software-related defects observed in
medical device user interfaces [52].
Opportunities
Because of the intangible nature of apps and the fact that they
can be easily updated in situ, assessment and classification at
a single point in time may not be feasible or appropriate. Obiodu
and Obiodu [40] suggest that one way to deal with the issue of
certification might be producing evidence-based guidelines for
designing health apps rather than trying to strictly regulate them.
We agree with this point, but would see an opportunity to take
this further. Rather than just relying on guidelines issued by
authorities, patient groups could produce best practice guidelines
for specific conditions and, by following the example of open
hardware initiatives, publish them openly to encourage
collaboration with other patient groups, app developers, and
mobile phone manufacturers, who are already starting to release
health care kits [53].
Conclusions
For medical technology, standards and regulations are needed
to ensure safety, protect the public, and guarantee that products
are fit for purpose. However, in the context of novel and
personal medical technologies, the current approach to
regulation is not only infeasible and difficult to enforce, but
also work against health care innovation. Given that it is
inevitable that three-dimensional-printed components, mobile
devices, and apps will be used to support and deliver health
care, as well as have impact on medical practice, regulators may
need to rethink their approach.
Based on our work, we have presented the benefits of new
technologies and personal medical devices. In many cases,
growing pressure on health services makes their introduction
inevitable. At the same time, we have outlined some of the
regulatory challenges. For example, by allowing for rapid
manufacturing of bespoke components, three-dimensional
printing raises concerns regarding quality control; the standards
underpinning the usability of personal mobile medical devices
are not enough to guarantee the “design meets users’ needs”
concept; in addition, mobile phone apps may or may not be
certified, depending on how a product is described. These
challenges open up new possibilities and encourage new ways
of thinking.
The health care domain is not the only one feeling the impact
of these technologies. The situation resembles the issues with
touch-screen tablets being used in the office environment.
Although office work and office equipment are regulated (eg,
computer workstations), the health and safety regulations are
unlikely to apply to tablet computers when it is not possible to
easily control how or where they are being used [54]. Rather
than trying to regulate them, different, more flexible approaches
are needed. For example, by shifting focus away from the
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introduction of technology, and toward educating users about
the implications of using it (eg, raising awareness of human
factors), we allow those in different environments to make sure
their technology is safe and fits their needs. Although due
diligence occurs during the design of technology, continual
research and review aims to tailor the properties of equipment
with the needs of users and characteristics of the work
environment.
The same could apply to novel and personal health care
technologies. When it comes to testing for usability, we cannot
predict every possible combination of user and usage before the
deployment of technology. The alternative is to conduct research
into how equipment is really used. We then realize that
improvement will occur when a device is in situ, and this will
be specific to a given context. As we can rapidly iterate a design,
we can continually improve and share the benefit of this
improvement. Much of the existing guidance concerning safety
and usability needs updating to accommodate this approach.
There also needs to be a consideration of how adequate levels
of safety can be guaranteed, without making it prohibitive for
small organizations to create products with relatively short life
cycles. The problem with the existing approach to regulation is
that historically, those producing technology would be likely
to stay in business for extended periods, compared with the
hobbyists and small organizations producing apps, who would
rapidly develop and release technology, but then may not be in
place to support it in the future. In the past, we had traceability
and accountability, whereas in the present we have little
recompense if something goes wrong.
We suggest ways of addressing these challenges, such as
publishing documentation and making it openly available to
review, therefore increasing transparency; adding situated
methods to usability standards to cover people's everyday use
of personal health technology, and allowing patient groups to
review mobile phone apps, draft their own guidelines, and
collaborate with each other and with app developers. This would
help to ensure that patients’ needs are met. Realizing a code of
practice for app developers, such as PAS 277 [55], would help
to build confidence. There is also an opportunity to educate
those buying and using such technology on requirements relating
to safety and usability.
If there is a need to comply with medical device software
process standards (eg, IEC 62304 [56]), there have been recent
developments in guidance. There are now worked examples of
assessment process (ISO 33030 [57]); and support for process
tailored to the safety class of the software (IEC/TR 80002-3
[58]). There are groups such as Medi SPICE [59].
This viewpoint represents a series of observations from our own
research on the challenges of regulating health technology. We
hope to start a discussion about the obstacles and opportunities
in addressing the design of novel technologies within regulatory
frameworks. Given the need to address the increasing pressures
on health services, this discussion is urgently required. Future
research could apply a structured methodology to review this
context and a case study approach [60], to articulate practical,
balanced, and proportionate approaches in line with this
discussion.
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